Clinical Therapeutics/New Technology-Oral Agents
- You have accessDapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to BenchJhih-Yuan Shih, Yu-Wen Lin, Sudeshna Fisch, Juei-Tang Cheng, Nai-Wen Kang, Chon-Seng Hong, Zhih-Cherng Chen, Wei-Ting ChangDiabetes Jan 2021, 70 (1) 262-267; DOI: 10.2337/db20-0840
- Open AccessPrecision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of TreatmentJohn M. DennisDiabetes Oct 2020, 69 (10) 2075-2085; DOI: 10.2337/dbi20-0002
- Diabetes Education (115)
- Epidemiology-Aging (29)
- Epidemiology-Other (227)
- Exercise (54)
- Heart Failure (6)
- Immunology (88)
- Nutrition-Clinical (55)
- Obesity-Animal (58)
- Obesity-Human (74)
- Profiles in Progress (29)
- The RISE Consortium (13)
- Therapeutic Inertia (17)
- Transplantation (15)